Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877241295315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Virve Kärkkäinen und 10 weiteren Autor:innen. Beteiligte Einrichtung: NeuroCenter, Neurology, Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: Alzheimer Disease, Tears, Cytoskeleton, Eye Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Background
New biomarkers that improve diagnosis of Alzheimer's disease (AD) are warranted. Tear fluid (TF) containing variety of proteins that reflect pathophysiological changes of systemic diseases makes TF proteins potential biomarker candidates for AD.
Objective
We investigated the expression levels of TF proteins in persons with mild AD and cognitively healthy controls (CO) to find out if altered proteins may link to the AD pathophysiology.
Methods
We analyzed the data of the 53 study participants (34 COs, mean age 71 and Mini-Mental State Examination (MMSE) 28.9 ± 1.4 and 19 persons with AD, CDR 0.5–1, mean age 71 and MMSE 23.8 ± 2.8). All went through neurological status examination, cognitive tests, and ophthalmological examination. TF was collected using Schirmer strips. The TF protein content was evaluated via mass spectrometry-based proteomics and label-free quantification.
Results
Eleven proteins having a role either in protein repair and clearance system, or regulation of cytoskeleton, showed altered expression in AD group compared to CO group. Seven of them were significantly ( p ≤ 0.05) upregulated (Sti1, Twf1, Myl6, Otub1, Pls1 and Caza1) or, downregulated (HSP90) in AD group.
Conclusions
Altered expression of all these up- or downregulated proteins may be linked to AD pathophysiology. Thus, our results are encouraging for searching new biomarker candidates for AD. TF is potential biomarker candidate, because TF seems to reflect altered protein levels already in mild AD dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NeuroCenter, Neurology, Kuopio University Hospital, Kuopio, Finland.
- NeuroCenter, Neurosurgery, Kuopio University Hospital, Kuopio, Finland.
- Neurosurgery, Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
- Neurology, Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
- Faculty of Medicine and Health Technology, Eye and Vision Research, Tampere University, Tampere, Finland.
ORCID-Profile: Virve Kärkkäinen
Zitieren
APA
Kärkkäinen, V., Hannonen, S., Rusanen, M., Lehtola, J. M., Saari, T., Uusitalo, H., Leinonen, V., Thiede, B., Kaarniranta, K., Koivisto, A. M., & Utheim, T. P. (2025). Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877241295315
Vancouver
Kärkkäinen V, Hannonen S, Rusanen M, Lehtola JM, Saari T, Uusitalo H, et al. Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877241295315
BibTeX
@article{Krkkinen2025,
author = {Kärkkäinen, Virve and Hannonen, Sanna and Rusanen, Minna and Lehtola, Juha-Matti and Saari, Toni and Uusitalo, Hannu and Leinonen, Ville and Thiede, Bernd and Kaarniranta, Kai and Koivisto, Anne M and Utheim, Tor Paaske},
title = {Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877241295315}
}
EUVIMED